Skip to content

Memory and Emotion in Acute and Chronic Phases of Cerebrovascular Accident

Memory and Emotion in Acute and Chronic Phases of Cerebrovascular Accident

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02887105
Acronym
MEMOIRE ET EMO
Enrollment
76
Registered
2016-09-01
Start date
2012-12-31
Completion date
2014-04-30
Last updated
2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident

Brief summary

The purpose is to determine the relationship between anxiety and cognitive performances in patients with acute and chronic phases of cerebrovascular accident (CVA). Data from neuropsychological assessment concerning cognitive processes (working and episodic memory) sensitive to different dimensions of anxiety will be analyzed. The secondary purpose is to evaluate how some neurological (hemispherical lateralization of lesions), psychological (depression) and demographic (quality of life) variables can increase the effects of different dimensions of anxiety on cognitive processes, during the acute and/or chronic phase of CVA.

Detailed description

Data will be collected during usual neuropsychological evaluation and cerebral imagery examination (NIHSS, Rankin scale) of patients in acute (0-1 month) and chronic (6 months) phases of CVA.

Interventions

OTHERStandard neuropsychological assessment
OTHERBrain MRI

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Acute phase of carotid, vertebrobasilar or lacunar cerebrovascular accident with ischemic or hemorrhagic origin * Right-handed * Possible cooperation: understanding of French instructions * Normal or corrected vision * Normal or corrected hearing * Mini-mental state examination score higher than pathologic threshold according to age and sociocultural level of patient * Possible follow up of patient

Exclusion criteria

* Hearing problems * Vision problems * Right hemiplegia or acute monoparesis of right upper limb * Hemispatial neglect * Apraxia * Psychiatric or neurological history possibly interfering with neuropsychological evaluation * Important defect of working memory or executive functions

Design outcomes

Primary

MeasureTime frame
Evaluation of verbal episodic memory with RL/RI 16 item test6 months (from CVA)
Evaluation of verbal working memory with Wechsler memory scaleup to 1 month (from CVA)
Evaluation of visuospatial working memory with Wechsler memory scaleup to 1 month (from CVA)
Evaluation of visual episodic memory with Rey and Taylor figure test6 months (from CVA)
State of anxiety evaluated with STAI-YA scaleup to 1 month (from CVA)
Anxiety proneness evaluated with STAI-YB scaleup to 1 month (from CVA)
Apprehension anxiety evaluated with Penn State Worry Questionnaireup to 1 month (from CVA)
Evaluation of working memory updating with N-back verbal and visuospatial taskup to 1 month (from CVA)
Evaluation of working memory inhibition with Stimulus-response compatibility taskup to 1 month (from CVA)
Evaluation of working memory flexibility with Switching taskup to 1 month (from CVA)

Secondary

MeasureTime frame
Depression state evaluated with Back depression inventoryup to 1 month (from CVA)
Quality of life evaluated with SF-36 testafter 6 months from CVA
Hemispheric lateralization of lesions detected with MRIup to 1 month from CVA

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026